Fig. 6From: Eribulin normalizes pancreatic cancer-associated fibroblasts by simulating selected features of TGFβ inhibition Schematic representation illustrating the tumor-suppressive effects of eribulin through normalization of CAFs. Illustration showing a tumor-permissive microenvironment (blue) and indicating that eribulin modulates CAFs in a way that these cells are prompted to generate a normalized, tumor-suppressive (red), TMEBack to article page